Valuation: Ypsomed Holding AG

Capitalization 408.28Cr 524.83Cr 445.9Cr 385.54Cr 715.81Cr 49TCr 724.11Cr 4.84TCr 1.89TCr 24TCr 1.97TCr 1.93TCr 82TCr P/E ratio 2026 *
19.8x
P/E ratio 2027 * 22.7x
Enterprise value 424.95Cr 546.26Cr 464.1Cr 401.28Cr 745.04Cr 51TCr 753.68Cr 5.04TCr 1.96TCr 25TCr 2.05TCr 2.01TCr 85TCr EV / Sales 2026 *
5.95x
EV / Sales 2027 * 6.22x
Free-Float
28.05%
Yield 2026 *
1.06%
Yield 2027 * 1.21%
1 day-3.61%
1 week+3.37%
Current month+5.57%
1 month+2.20%
3 months-3.29%
6 months-7.33%
Current year-12.13%
1 week 275
Extreme 275
305
1 month 269.6
Extreme 269.6
305
Current year 260.5
Extreme 260.5
356.5
1 year 260.5
Extreme 260.5
441.5
3 years 220
Extreme 220
441.5
5 years 121.6
Extreme 121.6
441.5
10 years 102.4
Extreme 102.4
441.5
Manager TitleAgeSince
Chief Executive Officer 49 01/07/2014
Director of Finance/CFO 42 01/04/2024
Chief Operating Officer 62 01/10/2015
Director TitleAgeSince
Director/Board Member 49 29/06/2022
Director/Board Member 64 01/01/2018
Director/Board Member 56 01/01/2019
Change 5d. change 1-year change 3-years change Capi.($)
-3.61%+3.37%-17.66%+30.70% 524.83Cr
-1.90%-4.38%-36.16%-22.87% 15TCr
-1.49%-3.99%-8.14%-14.84% 10TCr
-0.15%-5.60%+52.23%+84.24% 5.88TCr
+4.07%-12.80%-6.58%+57.59% 4.97TCr
-3.11%-0.50%-11.54%-40.93% 4.36TCr
-5.34%-11.40% - - 3.54TCr
-0.26%-1.21%-28.98%-49.57% 2.35TCr
+0.59%+7.52%+50.55%-11.93% 2.27TCr
-1.88%-2.31%-7.27%+10.83% 2.1TCr
Average -1.28%-1.66%-1.51%+4.80% 5.12TCr
Weighted average by Cap. -1.17%-4.08%-8.04%+0.07%

Financials

2026 *2027 *
Net sales 71Cr 92Cr 78Cr 67Cr 125.21Cr 8.65TCr 126.67Cr 846.54Cr 329.83Cr 4.15TCr 344.37Cr 337.22Cr 14TCr 70Cr 90Cr 76Cr 66Cr 122.13Cr 8.44TCr 123.55Cr 825.71Cr 321.72Cr 4.05TCr 335.89Cr 328.93Cr 14TCr
Net income 20Cr 26Cr 22Cr 19Cr 36Cr 2.46TCr 36Cr 240.87Cr 94Cr 1.18TCr 98Cr 96Cr 4.09TCr 18Cr 23Cr 20Cr 17Cr 32Cr 2.19TCr 32Cr 213.87Cr 83Cr 1.05TCr 87Cr 85Cr 3.63TCr
Net Debt 17Cr 21Cr 18Cr 16Cr 29Cr 2.02TCr 30Cr 197.62Cr 77Cr 969.75Cr 80Cr 79Cr 3.35TCr 25Cr 32Cr 27Cr 23Cr 43Cr 3TCr 44Cr 293.29Cr 114.27Cr 1.44TCr 119.31Cr 116.83Cr 4.98TCr
Logo Ypsomed Holding AG
Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.
Employees
2,000
Date Price Change Volume
08/26/08 288.20 CHF -3.68% 9,026
07/26/07 299.20 CHF +7.16% 37,774
06/26/06 279.20 CHF -0.78% 18,328
05/26/05 281.40 CHF +0.93% 13,482
04/26/04 278.80 CHF +2.12% 17,375
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
299.20CHF
Average target price
390.60CHF
Spread / Average Target
+30.55%

Quarterly revenue - Rate of surprise